Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)

University of Campania Luigi Vanvitelli100 enrolled

Overview

All patients with orthotopic liver transplantation who are evaluated and followed at each participating centers will be recorded in this study. Within this register a characterization of patients and therapy will be done. Prognostic factors of defined clinical relevant endpoints will be evaluated.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Liver Transplant; Complications Cardiovascular Complication Cardiovascular; Attack Cardiovascular Stroke Death

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with ortothopic liver transplantation and at least 2 year follow-up at the referral center Exclusion Criteria: * Missing Informed Consent Form * Missing Contact Informations for Follow up

Locations (2)

Gragnano Hospital

Gragnano, SA, Italy

RECRUITING

University of Campania Luigi Vanvitelli

Napoli, Italy

RECRUITING

Outcomes

Primary Outcomes

Cardiovascular death

death due to cardiac causes (myocardial infraction and/or stroke)

Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months

cardiovascular complication

fatal and non fatal myocardial infraction and/or stroke

Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months

Central Contacts

Alfredo Caturano, MD

CONTACT

+393338616985 alfredo.caturano@unicampania.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.